Debut Plus

₹2,231.2

▼ -55.8 -2.44%

17 Jul 2026

NSE Listed · Pharmaceuticals

Glenmark Pharmaceuticals (GLENMARK)

Volume: 2,03,674Avg Vol 1W: 1,06,366Avg Vol 1M: 2,71,06552W Range:₹1,792.6₹2,474
NSE BSE www.glenmarkpharma.com
Key Ratios
Checked 1h ago
Market Cap₹63,117 Cr
Current Price₹2,231.2
Previous Close₹2,287
High / Low (52w)₹2,474 / ₹1,792.6
Volume2,03,674
Avg Vol (1W)1,06,366
Avg Vol (1M)2,71,065
Stock P/E21.38
Book Value₹372.5
Dividend Yield11%
ROE28.08%
ROA6.84%
Revenue (TTM)—
Revenue Growth12.77%
Profit Margin8.15%
Total Debt₹513 Cr
Shares Outstanding28 Cr
Face Value₹1
EPS (TTM)₹104.59
P/B6
Debt / Equity0.22
50 DMA₹2,215.11
200 DMA₹2,220.99
Day change-2.44%
Price Chart
₹2,231.2▲ 18.59% · 1Y
₹2420₹185023.0L
2025-11-25
2026-07-17

20-day avg volume: 2.7L shares

Pros
  • Healthy return on equity of 28.1%.
  • Pays a dividend yield of 11.0%.
  • Company is almost debt-free.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹3,244 Cr₹3,434 Cr₹3,388 Cr₹3,256 Cr₹3,264 Cr₹6,047 Cr₹3,901 Cr₹3,771 Cr
EBITDA₹502 Cr₹521 Cr₹509 Cr₹448 Cr₹477 Cr₹2,419 Cr₹760 Cr₹804 Cr
Net Profit₹340 Cr₹354 Cr₹348 Cr₹5 Cr₹47 Cr₹610 Cr₹403 Cr₹301 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹9,166 Cr₹10,074 Cr₹10,801 Cr₹10,994 Cr₹12,472 Cr₹11,872 Cr₹12,653 Cr₹13,435 Cr
EBITDA₹1,405 Cr₹1,468 Cr₹1,441 Cr₹1,691 Cr₹2,000 Cr₹1,355 Cr₹1,453 Cr₹1,979 Cr
Net Profit₹804 Cr₹925 Cr₹776 Cr₹970 Cr₹942 Cr₹297 Cr₹-1,502 Cr₹1,047 Cr
EPS28.4932.7827.534.3833.3710.53-53.2237.11
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹12,595 Cr₹13,289 Cr₹14,685 Cr₹15,604 Cr₹17,083 Cr₹19,372 Cr₹14,359 Cr₹16,050 Cr
Total Liabilities₹7,432 Cr₹7,684 Cr₹8,615 Cr₹8,539 Cr₹7,645 Cr₹9,532 Cr₹6,511 Cr₹7,200 Cr
Equity₹5,163 Cr₹5,605 Cr₹6,070 Cr₹7,064 Cr₹9,438 Cr₹9,839 Cr₹7,848 Cr₹8,849 Cr
Total Debt————————
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹2,000 Cr₹1,767 Cr₹1,859 Cr₹1,641 Cr₹1,667 Cr₹1,266 Cr₹782 Cr₹-147 Cr
Investing₹-1,013 Cr₹-699 Cr₹-784 Cr₹-675 Cr₹-333 Cr₹-528 Cr₹4,561 Cr₹2 Cr
Financing₹-468 Cr₹-739 Cr₹-445 Cr₹-442 Cr₹-520 Cr₹-77 Cr₹-3,906 Cr₹787 Cr
Free Cash Flow₹2,000 Cr₹1,767 Cr₹1,859 Cr₹1,641 Cr₹1,667 Cr₹1,266 Cr₹782 Cr₹-147 Cr
Shareholding
Promoter 46.65% Institutions 39.63% Public 13.72%
Efficiency & Working Capital
ROCE32.7%
Interest Coverage9.6
Dividend Payout—
Debtor Days92 d
Inventory Days83 d
Payable Days71 d
Cash Conversion Cycle104 d
Working Capital Days175 d
Shareholding Details

As of 2026-03-31

Promoter46.7%
FII20.3%
DII19.3%
Institutions39.6%
Public13.7%
Promoter Pledge0%
No. of Shareholders1,96,105
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters46.6%46.6%46.6%46.6%46.6%46.6%46.6%46.6%46.6%46.6%46.7%46.7%
FIIs25.5%24.8%23.7%21.4%21%23.1%23.5%23.2%20.6%20.7%19.2%20.3%
DIIs9.1%10.3%10.9%13.4%13.9%13.2%13.8%14.6%17.6%18.6%20.1%19.3%
Public18.7%18.2%18.7%18.6%18.4%17.1%16%15.6%15.1%14%14.1%13.7%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders2,36,9082,32,6852,09,9311,99,4511,92,6301,93,9491,95,0591,92,7241,90,2101,98,7892,01,5841,96,105
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Saldanha Family TrustShareholding of Promoter and Promoter Group45.4%12.82 Cr
Hdfc Mutual Fund - Hdfc Nifty 200 Momentum 30 IndePublic Shareholding6.1%1.72 Cr
Government Pension Fund GlobalPublic Shareholding3.8%1.07 Cr
Amansa Holdings Private LimitedPublic Shareholding2.2%62,51,753
Invesco India Large & Mid Cap FundPublic Shareholding1.9%53,14,592
Uti-healthcare FundPublic Shareholding1.3%35,78,281
Bandhan Balanced Advantage FundPublic Shareholding1.2%33,07,946
Blanche Elizabeth SaldanhaShareholding of Promoter and Promoter Group0.4%11,14,327
Glenn Mario SaldanhaShareholding of Promoter and Promoter Group0.4%10,07,004
Cherylann Maria PintoShareholding of Promoter and Promoter Group0.3%7,63,915
Robin Joseph PintoShareholding of Promoter and Promoter Group0.2%4,99,500
Neha SaldanhaShareholding of Promoter and Promoter Group0%26,000
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Blanche Elizabeth Saldanha00%2026-03-31
Glenn Mario Saldanha00%2026-03-31
Cherylann Maria Pinto00%2026-03-31
Robin Joseph Pinto00%2026-03-31
Neha Saldanha00%2026-03-31
Saldanha Family Trust00%2026-03-31
Hdfc Mutual Fund - Hdfc Nifty 200 Momentum 30 Inde00%2026-03-31
Invesco India Large & Mid Cap Fund00%2026-03-31
Uti-healthcare Fund00%2026-03-31
Bandhan Balanced Advantage Fund00%2026-03-31
Government Pension Fund Global00%2026-03-31
Amansa Holdings Private Limited00%2026-03-31
Board of Directors
NameDesignationYear
Glenn SaldanhaChairman / Executive Director / M D / Promoter2025
Cheryl PintoED / WTD / Promoter2025
Anurag MantriED / President / Global CFO2025
B E SaldanhaNon Executive Director2025
Sona Saira RamasastryIndependent Non Exe. Director2025
Dipankar BhattacharjeeIndependent Non Exe. Director2025
V R IyerIndependent Non Exe. Director2025
Pradeep Kumar SinhaIndependent Non Exe. Director2025
Harish KuberCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Pharmaceutical Products₹0 Cr—
Segments — Geography
RegionRevenueShare
India₹4,485 Cr48.6%
North America₹1,922 Cr20.8%
Europe₹1,195 Cr13%
Rest of the World ( Including Latin₹1,625 Cr17.6%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹12372828
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-31Board Meetings—
dividend2025-10-03₹2.5 (250%)Interim
dividend2025-09-15₹2.5 (250%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202518,84300401818,901
202511,687000011,687
2025841004018900
Insider / Designated-Person Trades

10 recent disclosure(s)

Mr. Praveen D KurkalDisposal · 500
Mr. Praveen D KurkalDisposal · 1,000
Mr. Praveen D KurkalDisposal · 1,000
ROBIN PINTOAcquisition · 250
SRIDHAR GORTHIDisposal · 559
NEHA SALDANHAAcquisition · 20,000
Substantial Acquisitions (SAST)

1 disclosure(s)

Market17/06/2025 · 3,57,499
Company Information
Incorporated1977
ChairmanGlenn Saldanha
AuditorSuresh Surana & Associates LLP
Investor Email[email protected]
🌐 www.glenmarkpharma.com ↗

📍 B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai, Maharashtra, 400026

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Grover Jewells LimitedGK Energy LimitedGujarat Kidney N Sup Sp LimitedGKW LimitedGland Pharma LimitedGlaxoSmithKline Pharma Ltd.Gujarat Lease Financing LimitedGlobal Education LimitedGlobale Tessile LimitedGlobal Pet Industries Ltd.Global Vec Helicorp Ltd.Globe Enterprise (I) Ltd.All “G” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search